According to SIGA Technologies's latest financial reports and stock price the company's current number of shares outstanding is 71,084,735. At the end of 2023 the company had 71,084,735 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 71.08 M | -2.66% |
2022 | 73.02 M | -2.43% |
2021 | 74.84 M | -4.15% |
2020 | 78.08 M | -3.68% |
2019 | 81.06 M | 1.3% |
2018 | 80.02 M | 1.41% |
2017 | 78.9 M | 45.36% |
2016 | 54.28 M | 0.68% |
2015 | 53.91 M | 0.78% |
2014 | 53.5 M | 1.82% |
2013 | 52.54 M | 1.76% |
2012 | 51.63 M | 1.64% |
2011 | 50.8 M | 11.64% |
2010 | 45.5 M | 20.79% |
2009 | 37.67 M | 7.31% |
2008 | 35.1 M | 4.74% |
2007 | 33.51 M | 21.2% |
2006 | 27.65 M | 12.88% |
2005 | 24.5 M | 4.51% |
2004 | 23.44 M | 39.33% |
2003 | 16.82 M | 65.37% |
2002 | 10.17 M | 18.66% |
2001 | 8.57 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | 88,889,000 | 25.05% | ๐บ๐ธ USA |
Novavax NVAX | 103,429,000 | 45.50% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | 47,261,000 | -33.51% | ๐บ๐ธ USA |
NanoViricides NNVC | 11,745,906 | -83.48% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | 189,644,000 | 166.79% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 51,800,000 | -27.13% | ๐บ๐ธ USA |